Medication Summary

The best treatment for a gram-negative toe infection is often a combined approach by using both antibacterial agents and antifungal agents; sometimes, astringents are used.^[32]Debridement may be of value. Drying of the interdigital spaces is paramount. Sertaconazole nitrate cream 2% or any comparable azole or allylamine is beneficial the treatment of tinea pedis interdigitalis.^[33]

Class Summary

The mechanism of action may involve increasing the permeability of the cell membrane, which, in turn, causes intracellular components to leak.

Econazole topical (Ecoza)

View full drug information

Econazole nitrate cream is an antifungal agent that is a water-miscible base consisting of pegoxol 7 stearate, peglicol 5 oleate, mineral oil, benzoic acid, butylated hydroxyanisole, and purified water. The color of the soft cream is white to off white, and it is for topical use only. It exhibits broad-spectrum activity against many gram-negative organisms. Econazole nitrate cream 1% is supplied in tubes of 15 g, 30 g, and 85 g.

Class Summary

Therapy must cover all likely pathogens in the context of the clinical setting.

Cefotaxime (Claforan)

View full drug information

This is a third-generation semisynthetic broad-based antibiotic with a gram-negative spectrum. It has lower efficacy against gram-positive organisms. Specimens for bacteriologic culture should be obtained prior to therapy to test for susceptibilities to cefotaxime.

Ciprofloxacin (Cipro)

View full drug information

Ciprofloxacin is a synthetic broad-spectrum antimicrobial agent that inhibits bacterial DNA synthesis and, consequently, growth. The film-coated tablet is available in 100 mg, 250 mg, 500 mg, and 750 mg. The oral suspension is white to slightly yellow with a strawberry flavor and may contain yellow-orange droplets. Tablets are well absorbed in the gastrointestinal tract after oral administration. Ciprofloxacin has a wide range of activity against gram-negative organisms.

Gentamicin sulfate (G-Myticin, Jenamicin, Garamycin)

View full drug information

Gentamicin sulfate is a wide-spectrum antibiotic that provides highly effective topical treatment in primary and secondary bacterial infections of the skin. Gentamicin sulfate may clear infections that have not responded to other topical antibiotic agents. It treats superinfections caused by fungi or viruses. It treats skin and skin structure infections. The usual duration of treatment is 7-10 days. In more serious infections, a longer course of therapy is needed. Patients should be well hydrated during treatment. Gentamicin sulfate may also be used parenterally as a water-soluble injection against a wide variety of pathogenic bacteria. It may be considered as initial therapy in suggested or confirmed gram-negative infections, and therapy may be instituted before obtaining results of susceptibility testing.

Aste N, Atzori L, Zucca M, Pau M, Biggio P. Gram-negative bacterial toe web infection: a survey of 123 cases from the district of Cagliari, Italy. J Am Acad Dermatol. 2001 Oct. 45(4):537-41. [QxMD MEDLINE Link].
Karaca S, Kulac M, Cetinkaya Z, Demirel R. Etiology of foot intertrigo in the District of Afyonkarahisar, Turkey: a bacteriologic and mycologic study. J Am Podiatr Med Assoc. 2008 Jan-Feb. 98(1):42-4. [QxMD MEDLINE Link].
Devraj A, Siva Tez Pinnamaneni V, Biswal M, Ramachandran R, Jha V. Extranasal Staphylococcus aureus colonization predisposes to bloodstream infections in patients on hemodialysis with noncuffed internal jugular vein catheters. Hemodial Int. 2017 Jan. 21 (1):35-40. [QxMD MEDLINE Link].
Kates SG, Myung KB, McGinley KJ, Leyden JJ. The antibacterial efficacy of econazole nitrate in interdigital toe web infections. J Am Acad Dermatol. 1990 Apr. 22(4):583-6. [QxMD MEDLINE Link].
Rozenblat M, Last O, Fisher S, Ziv M. Acetic acid treatment for toe web infection caused by Pseudomonas Aeruginosa combined with fungal infection: A case series of ten patients. Dermatol Ther. 2019 Mar 28. e12883. [QxMD MEDLINE Link].
Dias LM, Ferrisse TM, Medeiros KS, et al. Use of Photodynamic Therapy Associated with Antimicrobial Peptides for Bacterial Control: A Systematic Review and Meta-Analysis. Int J Mol Sci. 2022 Mar 17. 23 (6):3226. [QxMD MEDLINE Link]. [Full Text].
King DF, King LA. Importance of debridement in the treatment of gram-negative bacterial toe web infection. J Am Acad Dermatol. 1986 Feb. 14(2 Pt 1):278-9. [QxMD MEDLINE Link].
Leyden JJ. Progression of interdigital infections from simplex to complex. J Am Acad Dermatol. 1993 May. 28(5 Pt 1):S7-S11. [QxMD MEDLINE Link].
Hay RJ. Gram Negative Toe Web Infection - A Not So Rare but Neglected Syndrome. Acta Derm Venereol. 2019 Oct 30. 99 (12):1070. [QxMD MEDLINE Link].
Spernovasilis N, Psichogiou M, Poulakou G. Skin manifestations of Pseudomonas aeruginosa infections. Curr Opin Infect Dis. 2021 Apr 1. 34 (2):72-79. [QxMD MEDLINE Link].
Schwartz RA, Reynoso-Vasquez N, Kapila R. Chloronychia: The Goldman-Fox Syndrome - Implications for Patients and Healthcare Workers. Indian J Dermatol. 2020 Jan-Feb. 65 (1):1-4. [QxMD MEDLINE Link].
Schwartz RA, Kapila R. The Goldman-Fox syndrome: Treating and preventing green pseudomonas nails in the era of COVID-19. Dermatol Ther. 2021 Jan. 34 (1):e14624. [QxMD MEDLINE Link].
Vento TJ, Cole DW, Mende K, Calvano TP, Rini EA, Tully CC, et al. Multidrug-resistant gram-negative bacteria colonization of healthy US military personnel in the US and Afghanistan. BMC Infect Dis. 2013 Feb 5. 13:68. [QxMD MEDLINE Link]. [Full Text].
Chen S, Tan X, Li X, Zhao T. Association between the duration of diabetes and gram-negative bacterial infection in diabetic foot infections: a case-control study. Endocr J. 2022 Sep 28. 69 (9):1061-1065. [QxMD MEDLINE Link]. [Full Text].
Mokni M, Dupuy A, Denguezli M. Risk factors for erysipelas of the leg in Tunisia: a multicenter case-control study. Dermatology. 2006. 212(2):108-12. [QxMD MEDLINE Link].
Day MR, Day RD, Harkless LB. Cellulitis secondary to web space dermatophytosis. Clin Podiatr Med Surg. 1996 Oct. 13(4):759-66. [QxMD MEDLINE Link].
Siljander T, Karppelin M, Vähäkuopus S, Syrjänen J, Toropainen M, Kere J, et al. Acute bacterial, nonnecrotizing cellulitis in Finland: microbiological findings. Clin Infect Dis. 2008 Mar 15. 46(6):855-61. [QxMD MEDLINE Link].
Park JW, Jeong GJ, Seo SJ, Li K. Pseudomonas toe web infection and autosensitisation dermatitis: Diagnostic and therapeutic challenge. Int Wound J. 2020 Oct. 17 (5):1543-1544. [QxMD MEDLINE Link].
Honig PJ, Frieden IJ, Kim HJ, Yan AC. Streptococcal intertrigo: an underrecognized condition in children. Pediatrics. 2003 Dec. 112(6 Pt 1):1427-9. [QxMD MEDLINE Link].
Diongue K, Ndiaye M, Diallo MA, Seck MC, Badiane AS, Diop A, et al. Fungal interdigital tinea pedis in Dakar (Senegal). J Mycol Med. 2016 May 12. [QxMD MEDLINE Link].
Romano C, Presenti L, Massai L. Interdigital intertrigo of the feet due to therapy-resistant Fusarium solani. Dermatology. 1999. 199(2):177-9. [QxMD MEDLINE Link].
Galkowska H, Podbielska A, Olszewski WL, Stelmach E, Luczak M, Rosinski G, et al. Epidemiology and prevalence of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis in patients with diabetic foot ulcers: focus on the differences between species isolated from individuals with ischemic vs. neuropathic foot ulcers. Diabetes Res Clin Pract. 2009 May. 84(2):187-93. [QxMD MEDLINE Link].
Ilkit M, Gumral R, Saracli MA, Burgut R. Trichophyton tonsurans scalp carriage among wrestlers in a national competition in Turkey. Mycopathologia. 2011 Apr 7. [QxMD MEDLINE Link].
Lin JY, Shih YL, Ho HC. Foot bacterial intertrigo mimicking interdigital tinea pedis. Chang Gung Med J. 2011 Jan-Feb. 34(1):44-9. [QxMD MEDLINE Link].
Ronjat L, Ferneiny M, Hadj-Rabia S, Boccara O, Bodemer C. [Generalized exanthematous pustular dermatophytid, a rare clinical presentation of dermatophytid reaction]. Ann Dermatol Venereol. 2015 Apr. 142 (4):270-5. [QxMD MEDLINE Link].
Vanhooteghem O, Szepetiuk G, Paurobally D, Heureux F. Chronic interdigital dermatophytic infection: A common lesion associated with potentially severe consequences. Diabetes Res Clin Pract. 2011 Jan. 91(1):23-5. [QxMD MEDLINE Link].
Aragón-Sánchez J, Lipsky BA, Lázaro-Martínez JL. Gram-negative diabetic foot osteomyelitis: risk factors and clinical presentation. Int J Low Extrem Wounds. 2013 Mar. 12(1):63-8. [QxMD MEDLINE Link].
Inghammar M, Rasmussen M, Linder A. Recurrent erysipelas--risk factors and clinical presentation. BMC Infect Dis. 2014 May 18. 14:270. [QxMD MEDLINE Link]. [Full Text].
Müller DP, Hoffmann R, Welzel J. Microorganisms of the toe web and their importance for erysipelas of the leg. J Dtsch Dermatol Ges. 2014 Aug. 12(8):691-5. [QxMD MEDLINE Link].
Inci M, Serarslan G, Ozer B, Inan MU, Evirgen O, Erkaslan Alagoz G, et al. The prevalence of interdigital erythrasma in southern region of Turkey. J Eur Acad Dermatol Venereol. 2011 Oct 7. [QxMD MEDLINE Link].
Ramírez-Hobak L, Moreno-Coutiño G, Arenas-Guzmán R, Gorzelewski A, Fernández-Martínez R. [Treatment of interdigital foot Erythrasma with ozonated olive oil]. Rev Med Inst Mex Seguro Soc. 2016 Jul-Aug. 54 (4):458-61. [QxMD MEDLINE Link].
Weidner T, Tittelbach J, Illing T, Elsner P. Gram-negative bacterial toe web infection - a systematic review. J Eur Acad Dermatol Venereol. 2018 Jan. 32 (1):39-47. [QxMD MEDLINE Link].
Borelli C, Korting HC, Bödeker RH, Neumeister C. Safety and efficacy of sertaconazole nitrate cream 2% in the treatment of tinea pedis interdigitalis: a subgroup analysis. Cutis. 2010 Feb. 85(2):107-11. [QxMD MEDLINE Link].
Bjornsdottir S, Gottfredsson M, Thorisdottir AS, Gunnarsson GB, Ríkardsdottir H, Kristjansson M, et al. Risk factors for acute cellulitis of the lower limb: a prospective case-control study. Clin Infect Dis. 2005 Nov 15. 41(10):1416-22. [QxMD MEDLINE Link].
Janniger CK, Schwartz RA, Szepietowski JC, Reich A. Intertrigo and common secondary skin infections. Am Fam Physician. 2005 Sep 1. 72(5):833-8. [QxMD MEDLINE Link].

Media Gallery

A 33-year-old man with interweb exudative patches. Courtesy of Rajendra Kapila, MD, Professor of Infectious Diseases, New Jersey Medical School.

of 1

Author

Robert A Schwartz, MD, MPH Professor and Head of Dermatology, Professor of Pathology, Professor of Pediatrics, Professor of Medicine, Rutgers New Jersey Medical School

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, New York Academy of Medicine, Royal College of Physicians of Edinburgh, Sigma Xi, The Scientific Research Honor Society

Disclosure: Nothing to disclose.

Specialty Editor Board

David F Butler, MD Former Section Chief of Dermatology, Central Texas Veterans Healthcare System; Professor of Dermatology, Texas A&M University College of Medicine; Founding Chair, Department of Dermatology, Scott and White Clinic

David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, Association of Military Dermatologists, Phi Beta Kappa, Texas Dermatological Society

Disclosure: Nothing to disclose.

Rosalie Elenitsas, MD Herman Beerman Professor of Dermatology, University of Pennsylvania School of Medicine; Director, Penn Cutaneous Pathology Services, Department of Dermatology, University of Pennsylvania Health System

Rosalie Elenitsas, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, American Society of Dermatopathology, Pennsylvania Academy of Dermatology

Disclosure: Received royalty from Lippincott Williams Wilkins for textbook editor.

Chief Editor

William D James, MD Paul R Gross Professor of Dermatology, Vice-Chairman, Residency Program Director, Department of Dermatology, University of Pennsylvania School of Medicine

William D James, MD is a member of the following medical societies: American Academy of Dermatology, Society for Investigative Dermatology

Disclosure: Received income in an amount equal to or greater than $250 from: Elsevier; WebMD<br/>Served as a speaker for various universities, dermatology societies, and dermatology departments.

Additional Contributors

Takeji Nishikawa, MD Emeritus Professor, Department of Dermatology, Keio University School of Medicine; Director, Samoncho Dermatology Clinic; Managing Director, The Waksman Foundation of Japan Inc

Disclosure: Nothing to disclose.

Acknowledgements

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous authors, Dr. Frantisek Vosmik, and Jarrett R. Hesselbirg, MD, to the development and writing of this article.